DEANDRA SMITH: Open Payments
NPI 1144926676 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,782 in 108 payments from 11 companies in 2025. Trend: 2023 $1,241 · 2024 $3,106 · 2025 $3,782
Food & beverage: $3,782
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 23 | $698 |
| Alkermes, Inc. | 18 | $666 |
| Axsome Therapeutics, Inc. | 12 | $541 |
| E.R. Squibb & Sons, L.L.C. | 15 | $482 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $454 |
| Neurocrine BioSciences, Inc. | 11 | $393 |
| Teva Pharmaceuticals USA, Inc. | 8 | $235 |
| Otsuka America Pharmaceutical, Inc. | 6 | $205 |
| ABBVIE INC. | 3 | $63 |
| Biogen, Inc. | 1 | $23 |
Products named: INVEGA SUSTENNA, Auvelity, COBENFY, CAPLYTA, ARISTADA, INGREZZA, LYBALVI, REXULTI.
Industry payments across TN — which companies pay providers there.
